Expression of circadian genes correlates with liver metastasis and outcomes in colorectal cancer

Oncology Reports

Volumn 25, Issue 5, 2011, Pages 1439-1446

  Oshima, Takashi ^a   Takenoshita, Seiich ^b   Akaike, Makoto ^c   Kunisaki, Chikara ^a   Fujii, Shoich ^a   Nozaki, Akito ^a   Numata, Kazushi ^a   Shiozawa, Manabu ^c   Rino, Yasushi ^d   Tanaka, Katsuaki ^a   Masuda, Munetaka ^d   Imada, Toshio ^d  

^a YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^c KANAGAWA CANCER CENTER   (Japan)

^d YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Bmal1; Circadian genes; Colorectal cancer; Liver metastasis; Period1; Period2; Prognostic factor

Indexed keywords

BETA ACTIN; CASEIN KINASE IEPSILON; CRYPTOCHROME 1; CRYPTOCHROME 2; MESSENGER RNA; PER1 PROTEIN; PER2 PROTEIN; PERIOD3 PROTEIN; PROTEIN BMAL1; TRANSCRIPTION FACTOR CLOCK; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER INVASION; CIRCADIAN RHYTHM; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE LOCATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME;

AGED; CIRCADIAN CLOCKS; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTESTINAL MUCOSA; LIVER NEOPLASMS; MALE; MIDDLE AGED; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 79953050613     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1207     Document Type: Article

References (33)

1. Stephan FK and Zucker I: Circadian rhythms in drinking behavior and locomotor activity of rats are eliminated by hypothalamic lesions. Proc Natl Acad Sci USA 69: 1583-1586, 1972.
2. Bartness TJ, Song CK and Demas GE: SCN efferents to peripheral tissues: implications for biological rhythms. J Biol Rhythms 16: 196-204, 2001. (Pubitemid 32516194)
3. Reppert SM and Weaver DR: Coordination of circadian timing in mammals. Nature 418: 935-941, 2002.
4. Herzog ED: Neurons and networks in daily rhythms. Nat Rev Neurosci 8: 790-802, 2007.
5. Liu AC, Welsh DK, Ko CH, et al: Intercellular coupling confers robustness against mutations in the SCN circadian clock network. Cell 129: 605-616, 2007. (Pubitemid 46660967)
6. Kuhlman SJ and McMahon DG: Encoding the ins and outs of circadian pacemaking. J Biol Rhythms 21: 470-481, 2006. (Pubitemid 44706828)
7. Lee C, Etchegaray JP, Cagampang FR, Loudon AS and Reppert SM: Posttranslational mechanisms regulate the mammalian circadian clock. Cell 107: 855-867, 2001. (Pubitemid 34084977)
8. Ko CH and Takahashi JS: Molecular components of the mammalian circadian clock. Hum Mol Genet 15: R271-R277, 2006. (Pubitemid 44446803)
9. Schibler U: The daily timing of gene expression and physiology in mammals. Dialogues Clin Neurosci 9: 257-272, 2007.
10. Oishi K, Miyazaki K, Kadota K, et al: Genome-wide expression analysis of mouse liver reveals CLOCK-regulated circadian output genes. J Biol Chem 278: 41519-41527, 2003. (Pubitemid 37280981)
11. Lowrey PL and Takahashi JS: Mammalian circadian biology, elucidating genome-wide levels of temporal organization. Annu Rev Genomics Hum Genet 5: 407-441, 2004. (Pubitemid 39362752)
12. Schernhammer ES, Laden F, Speizer FE, et al: Rotating night shifts and risk of breast cancer in women participating in the nurses' health study. J Natl Cancer Inst 93: 1563-1568, 2001. (Pubitemid 32998486)
13. Schernhammer ES, Laden F, Speizer FE, et at Night-shift work and risk of colorectal cancer in the nurses' health study. J Natl Cancer Inst 95: 825-828, 2003. (Pubitemid 36798430)
14. Viswanathan AN, Hankinson SE and Schernhammer ES: Night shift work and the risk of endometrial cancer. Cancer Res 67: 10618-10622, 2007. (Pubitemid 350070839)
15. Sack RL, Auckley D, Auger RR, et al: Circadian rhythm sleep disorders: part I, basic principles, shift work and jet lag disorders. An American Academy of Sleep Medicine review. Sleep 30: 1460-1483, 2007. (Pubitemid 350036973)
16. Filipski E, King VM, Li X, et al: Host circadian clock as a control point in tumor progression. J Natl Cancer Inst 94: 690-697, 2002. (Pubitemid 34552490)
17. Koyanagi S, Kuramoto Y, Nakagawa H, et al: A molecular mechanism regulating circadian expression of vascular endothelial growth factor in tumor cells. Cancer Res 63: 7277-7283, 2003. (Pubitemid 37413468)
18. Cao Q, Gery S, Dashti A, Zhou Y, Gu J and Koeffler HP: A role for the clock gene per1 in prostate cancer. Cancer Res 69: 7619-7625, 2009.
19. Fu L, Pelicano H, Liu J, Huang P and Lee C: The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 111: 41-50, 2002.
20. Hua H, Wang Y, Wan C, et al: Circadian gene mPer2 overexpression induces cancer cell apoptosis. Cancer Sci 97 589-596, 2006. (Pubitemid 44056606)
21. Oda A, Katayose Y, Yabuuchi S, et al: Clock gene mouse period2 overexpression inhibits growth of human pancreatic cancer cells and has synergistic effect with cisplatin. Anticancer Res 29: 1201-1209, 2009.
22. Chen ST, Choo KB, Hou MF, Yeh KT, Kuo SJ and Chang JG: Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers. Carcinogenesis 26: 1241-1246, 2005.
23. Winter SL, Bosnoyan-Collins L, Pinnaduwage D and Andrulis IL: Expression of the circadian clock genes Per1 and Per2 in sporadic and familial breast tumors. Neoplasia 9: 797-800, 2007. (Pubitemid 47623419)
24. Yeh KT, Yang MY, Liu TC, et al: Abnormal expression of period 1 (PER1) in endometrial carcinoma. J Pathol 206: 111-120, 2005.
25. Yang WS and Stockwell BR: Inhibition of casein kinase 1-epsilon induces cancer-cell-selective, PERIOD2-dependent growth arrest. Genome Biol 9: R92, 2008.
26. Roy PG and Thompson AM: Cyclin D1 and breast cancer. Breast 15: 718-727, 2008. (Pubitemid 44774238)
27. Koyanagi S, Kuramoto Y, Nakagawa H, et al: A molecular mechanism regulating circadian expression of vascular endothelial growth factor in tumor cells. Cancer Res 63: 7277-7283, 2003. (Pubitemid 37413468)
28. Taniguchi H, Fernández AF, Setién F, et al: Epigenetic inactivation of the circadian clock gene BMAL1 in hematologic malignancies. Cancer Res 69: 8447-8454, 2009.
29. Kuo SJ, Chen ST, Yeh KT, et al: Disturbance of circadian gene expression in breast cancer. Virchows Arch 454: 467-474, 2009.
30. Chen-Goodspeed M and Lee CC: Tumor suppression and circadian function. J Biol Rhythms 22: 291-298, 2007.
31. Sjöblom T, Jones S, Wood LD, et al: The consensus coding sequences of human breast and colorectal cancers. Science 314: 268-274, 2006. (Pubitemid 44571966)
32. Hua H, Wang Y, Wan C, et al: Inhibition of tumorigenesis by intratumoral delivery of the circadian gene mPer2 in C57BL/6 mice. Cancer Gene Ther 14: 815-818, 2007. (Pubitemid 47262754)
33. Gery S, Virk RK, Chumakov K, Yu A and Koeffler HP: The clock gene Per2 links the circadian system to the estrogen receptor. Oncogene 26: 7916-7920, 2007. (Pubitemid 350262755)